Evidence map›Paper›PMID 33116509›Full record

ArticleInternational journal of nanomedicine2020

Magnetite Nanoparticles and Spheres for Chemo- and Photothermal Therapy of Hepatocellular Carcinoma in vitro.

Artur Jędrzak, Bartosz F Grześkowiak, Klaudia Golba, Emerson Coy, Karol Synoradzki, Stefan Jurga, Teofil Jesionowski, Radosław Mrówczyński

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Artur JędrzakNanoBioMedical Centre, Adam Mickiewicz University in Poznan, Poznan PL-61614, Poland.
Bartosz F GrześkowiakNanoBioMedical Centre, Adam Mickiewicz University in Poznan, Poznan PL-61614, Poland.
Klaudia GolbaNanoBioMedical Centre, Adam Mickiewicz University in Poznan, Poznan PL-61614, Poland.ORCID 0000-0002-6177-0194
Emerson CoyNanoBioMedical Centre, Adam Mickiewicz University in Poznan, Poznan PL-61614, Poland.ORCID 0000-0002-4149-9720
Karol SynoradzkiNanoBioMedical Centre, Adam Mickiewicz University in Poznan, Poznan PL-61614, Poland.ORCID 0000-0002-7732-3284
Stefan JurgaNanoBioMedical Centre, Adam Mickiewicz University in Poznan, Poznan PL-61614, Poland.ORCID 0000-0002-1665-6077
Teofil JesionowskiInstitute of Chemical Technology and Engineering, Faculty of Chemical Technology, Poznan University of Technology, Poznan PL-60965, Poland.ORCID 0000-0002-7808-8060
Radosław MrówczyńskiNanoBioMedical Centre, Adam Mickiewicz University in Poznan, Poznan PL-61614, Poland.ORCID 0000-0003-3687-911X
Adam Mickiewicz University in Poznań · PLPoznań University of Technology · PLInstitute of Molecular Physics of the Polish Academy of Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWe present a multimodal nanoplatforms for the treatment of hepatocellular carcinoma (HCC) in vitro. The nanoplatforms are based on polydopamine (PDA)-coated magnetite nanoparticles (NPs) and spheres (sMAG) with PAMAM dendrimers and functionalized with NHS-PEG-Mal ( MATERIALS AND

methodsAll materials are characterized in detail with transmission electron microscopy, Fourier transform infrared spectroscopy, thermogravimetric analysis, zeta potential and magnetic measurements. Also, photothermal properties were determined under irradiation of nanoparticles with laser beam of 2 W/cm

resultsBoth NPs and sMAG showed high photothermal properties. Nevertheless, the higher photothermal response was found for magnetic spheres. Materials of concentration above 10 µg/mL reveal that their activity was comparable to free doxorubicin. It is worth highlighting that a functionalized magnetic sphere with DOXO more strongly affected the HepG2 cells than smaller functionalized nanoparticles with DOXO in the performed chemotherapy. This can be attributed to the larger size of particles and a different method of drug distribution. In the further stage, both materials were assessed in combined chemo- and photothermal therapy (CT-PTT) which revealed that magnetic spheres were also more effective in this modality than smaller nanoparticles.

conclusionHere, we present two types of nanomaterials (nanoparticles and spheres) based on polydopamine and PAMAM dendrimers g.5.0 functionalized with NHS-PEG-Mal linker terminated with folic acid for in vitro hepatocellular carcinoma treatment. The obtained materials can serve as efficient agents for dual chemo- and photothermal therapy of HCC. We also proved that PDA-coated magnetic spheres were more efficient in therapies based on near-infrared irradiation because determined cell viabilities for those materials are lower than for the same concentrations of nanomaterials based on small magnetic nanoparticles.

Indexed as

PhototherapyAnimalsAntineoplastic AgentsCarcinoma, HepatocellularCell Line, TumorCombined Modality TherapyDendrimersDoxorubicinDrug CarriersDrug LiberationHumansIndolesLiver NeoplasmsMagnetite NanoparticlesPolyethylene GlycolsPolymersAntineoplastic AgentsDendrimersDoxorubicinDrug CarriersIndolesMagnetite NanoparticlesPAMAM StarburstpolydopaminePolyethylene GlycolsPolymersdrug deliveryliver cancermagnetic nanoparticlespolydopamine

Identifiers

PMID33116509
PMCPMC7569049
OpenAlexW3092862269

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.